CDK4/6 inhibitors, combined with hormone therapy, are now the standard treatment for an advanced type of breast cancer; specifically, the one that is characterized by the expression of hormone receptors (HR+) and HER2 negative (HER2-). This treatment works by blocking the proteins CDK4 and CDK6, which are responsible for controlling cell division and growth.
This article was originally published on MedicalXpress.com
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
Fostering a rewarding and fulfilling relationship is no easy task. You and your partner are only human, and, as the saying goes, you are going to make mistakes. However, learning the common relationship mistakes and […]
© 2025 SimplyWell.ca